2628 Stock Overview
Operates as a life insurance company in the People’s Republic of China.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 4/6 |
Rewards
Risk Analysis
China Life Insurance Company Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$10.48 |
52 Week High | HK$14.18 |
52 Week Low | HK$8.19 |
Beta | 0.74 |
11 Month Change | -7.91% |
3 Month Change | 1.75% |
1 Year Change | -22.26% |
33 Year Change | -19.26% |
5 Year Change | -46.26% |
Change since IPO | -51.37% |
Recent News & Updates
Recent updates
Shareholder Returns
2628 | HK Insurance | HK Market | |
---|---|---|---|
7D | -4.7% | -5.3% | -3.9% |
1Y | -22.3% | -21.6% | -5.5% |
Return vs Industry: 2628 matched the Hong Kong Insurance industry which returned -21.6% over the past year.
Return vs Market: 2628 underperformed the Hong Kong Market which returned -5.5% over the past year.
Price Volatility
2628 volatility | |
---|---|
2628 Average Weekly Movement | 4.8% |
Insurance Industry Average Movement | 5.2% |
Market Average Movement | 6.7% |
10% most volatile stocks in HK Market | 14.3% |
10% least volatile stocks in HK Market | 3.7% |
Stable Share Price: 2628 has not had significant price volatility in the past 3 months.
Volatility Over Time: 2628's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1949 | 100,000 | Mingguang Li | www.e-chinalife.com |
China Life Insurance Company Limited, together with its subsidiaries, operates as a life insurance company in the People’s Republic of China. The company operates in four segments: Life Insurance Business, Health Insurance Business, Accident Insurance Business, and Other Businesses. It offers critical illness protection, annuity, children/female/pension, security, life, medical, and accident protection insurance products.
China Life Insurance Company Limited Fundamentals Summary
2628 fundamental statistics | |
---|---|
Market cap | HK$768.91b |
Earnings (TTM) | HK$20.45b |
Revenue (TTM) | HK$797.34b |
14.6x
P/E Ratio0.4x
P/S RatioIs 2628 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
2628 income statement (TTM) | |
---|---|
Revenue | CN¥740.01b |
Cost of Revenue | CN¥658.99b |
Gross Profit | CN¥81.02b |
Other Expenses | CN¥62.04b |
Earnings | CN¥18.98b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 30, 2024
Earnings per share (EPS) | 0.67 |
Gross Margin | 10.95% |
Net Profit Margin | 2.57% |
Debt/Equity Ratio | 36.5% |
How did 2628 perform over the long term?
See historical performance and comparison